[#item_full_content] Record annual medical cannabis revenue and adjusted EBITDA were achieved, driven by strong international growth and strategic acquisitions. The outlook anticipates lower revenue and EBITDA due to Canadian pricing changes, with a continued focus on global medical markets.Original document: Aurora Ca… 
Read More
ACB: Record medical cannabis revenue and EBITDA, with focus shifting to global medical markets
ByPot Shop News
June 11, 2026